1,2,3,4,6-pentakis-O-galloyl-beta-D-glucose has been researched along with Breast Neoplasms in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 7 (77.78) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fan, C; Jiang, H; Luo, Q; Tang, J; Tao, Y; Tian, J; Xiang, Q; Xue, J | 1 |
| Chen, LH; Chen, YJ; Huang, C; Huang, HC; Lee, SY; Lin, CL; Tu, TH | 1 |
| Chai, Y; Jeong, SJ; Kim, SH; Lee, HJ; Lu, J; Nkhata, K; Shaik, AA; Xing, C; Zhang, J | 1 |
| Ahn, KS; Jeong, SJ; Jung, DB; Kim, SH; Koh, W; Lee, EO; Lee, HJ; Lü, J; Park, Y; Seo, NJ | 1 |
| Dong, Y; Hu, H; Li, J; Lü, J; Yin, S | 1 |
| Huang, HC; Lin, CL; Lin, JK | 1 |
| Bae, H; Chen, CY; Jang, HJ; Jeong, SJ; Khil, JH; Kim, JH; Kim, MS; Kim, SH; Kim, YC; Ko, E; Lee, HJ; Song, HS; Yu, WS | 1 |
| Chang, CY; Chen, WJ; Lin, JK | 1 |
| Hua, KT; Lin, JK; Way, TD | 1 |
9 other study(ies) available for 1,2,3,4,6-pentakis-O-galloyl-beta-D-glucose and Breast Neoplasms
| Article | Year |
|---|---|
In vitro study of anti-ER positive breast cancer effect and mechanism of 1,2,3,4-6-pentyl-O-galloyl-beta-d-glucose (PGG).
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Cycle Checkpoints; Cell Line, Tumor; Dose-Response Relationship, Drug; Female; Humans; Hydrolyzable Tannins; Receptors, Estrogen | 2019 |
Co-treatment with quercetin and 1,2,3,4,6-penta-O-galloyl-β-D-glucose causes cell cycle arrest and apoptosis in human breast cancer MDA-MB-231 and AU565 cells.
Topics: Antineoplastic Agents, Phytogenic; Antioxidants; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Female; G2 Phase Cell Cycle Checkpoints; Humans; Hydrolyzable Tannins; Quercetin | 2013 |
Penta-O-galloyl-beta-D-glucose induces G1 arrest and DNA replicative S-phase arrest independently of cyclin-dependent kinase inhibitor 1A, cyclin-dependent kinase inhibitor 1B and P53 in human breast cancer cells and is orally active against triple negati
Topics: Animals; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; ErbB Receptors; Female; G1 Phase Cell Cycle Checkpoints; Humans; Hydrolyzable Tannins; MCF-7 Cells; Mice; Mice, Nude; Receptors, Estrogen; Receptors, Progesterone; S Phase Cell Cycle Checkpoints; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays | 2010 |
Oral administration of penta-O-galloyl-β-D-glucose suppresses triple-negative breast cancer xenograft growth and metastasis in strong association with JAK1-STAT3 inhibition.
Topics: Animals; Apoptosis; Blotting, Western; Breast Neoplasms; Cell Proliferation; Electrophoretic Mobility Shift Assay; Female; Humans; Hydrolyzable Tannins; Immunoenzyme Techniques; Janus Kinase 1; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Small Interfering; Sodium-Potassium-Exchanging ATPase; STAT3 Transcription Factor; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2011 |
Penta-1,2,3,4,6-O-galloyl-beta-D-glucose induces senescence-like terminal S-phase arrest in human hepatoma and breast cancer cells.
Topics: Antineoplastic Agents, Phytogenic; Breast Neoplasms; Carcinoma, Hepatocellular; Cell Line, Tumor; Cellular Senescence; Cyclin-Dependent Kinase Inhibitor p21; Down-Regulation; Female; Humans; Hydrolyzable Tannins; Liver Neoplasms; Reactive Oxygen Species; S Phase; Tumor Suppressor Protein p53 | 2011 |
1,2,3,4,6-penta-O-galloyl-β-D-glucose, quercetin, curcumin and lycopene induce cell-cycle arrest in MDA-MB-231 and BT474 cells through downregulation of Skp2 protein.
Topics: Breast Neoplasms; Carotenoids; Cell Cycle; Cell Line, Tumor; Curcumin; Down-Regulation; Female; Humans; Hydrolyzable Tannins; Lycopene; Quercetin; S-Phase Kinase-Associated Proteins | 2011 |
The genome-wide expression profile of 1,2,3,4,6-penta-O-galloyl-β-D-glucose-treated MDA-MB-231 breast cancer cells: molecular target on cancer metabolism.
Topics: Angiogenesis Inhibitors; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Drugs, Chinese Herbal; Female; Genome-Wide Association Study; Glycolysis; Humans; Hydrolyzable Tannins; Microarray Analysis; Molecular Targeted Therapy; Pyruvic Acid; Rhus; Tyrosine | 2011 |
Induction of G1 phase arrest in MCF human breast cancer cells by pentagalloylglucose through the down-regulation of CDK4 and CDK2 activities and up-regulation of the CDK inhibitors p27(Kip) and p21(Cip).
Topics: Breast Neoplasms; CDC2-CDC28 Kinases; Cell Cycle Proteins; Cell Division; Cyclin D; Cyclin E; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Cyclin-Dependent Kinases; Cyclins; DNA; Down-Regulation; Enzyme Activation; G1 Phase; Humans; Hydrolyzable Tannins; Phosphorylation; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Retinoblastoma Protein; RNA, Messenger; Transcription, Genetic; Tumor Cells, Cultured; Tumor Suppressor Proteins; Up-Regulation | 2003 |
Pentagalloylglucose inhibits estrogen receptor alpha by lysosome-dependent depletion and modulates ErbB/PI3K/Akt pathway in human breast cancer MCF-7 cells.
Topics: Breast Neoplasms; Cell Line, Tumor; Cyclin D1; Estrogen Receptor alpha; Female; Humans; Hydrolyzable Tannins; Lysosomes; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Proto-Oncogene Proteins c-akt; Receptor, ErbB-2; Receptor, ErbB-3 | 2006 |